INDO US BIOTECH LTD Fair Value
INDOUS · FMCG · Current price ₹87.28
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹47 | 13% ROE fading to 13% over ~3 yrs, on ₹46 book |
| Relative P/E | ₹134 | EPS × 16.6 peer-median P/E |
| Graham floor | ₹92 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is INDO US BIOTECH LTD undervalued?
DocStoX estimates the fair value of INDO US BIOTECH LTD at ₹79 per share, versus the current market price of ₹87. That puts the stock about -10.1% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹47), Relative P/E (₹134), Graham floor (₹92). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹47 (bear) to ₹79 (base) to ₹134 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on INDO US BIOTECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.